ADR Biomedical Holdings Inc. (TYO:3750)
Japan · Delayed Price · Currency is JPY 788.00
+7.00 (0.90%)
Oct 6, 2026, 3:30 PM JST
ADR Biomedical Holdings Ratios and Metrics
Market cap in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Total Valuation
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 5, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 7,035 | 7,268 | 7,160 | 8,643 | 10,116 | 10,349 | |
Market Cap Growth | -8.69% | 1.49% | -17.15% | -14.56% | -2.25% | -17.56% |
Enterprise Value | 7,218 | 7,422 | 9,377 | 15,692 | 17,439 | 18,781 |
Last Close Price | 788.00 | 814.00 | 802.00 | 968.00 | 1133.00 | 1159.00 |
Price Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 5, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | - | - | - | 62.63 | - | - |
PS Ratio | 69.66 | 145.35 | 58.69 | 5.54 | 4.72 | 7.75 |
PB Ratio | -99.09 | 330.34 | 11.37 | 3.09 | 3.81 | 2.79 |
P/TBV Ratio | - | 330.34 | 11.40 | 3.12 | 5.15 | 3.48 |
EV Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 5, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
EV/Sales Ratio | 71.47 | 148.43 | 76.86 | 10.06 | 8.13 | 14.07 |
Financial Efficiency
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 5, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Debt / Equity Ratio | -3.52 | - | 4.20 | 0.88 | 3.20 | 2.49 |
Net Debt / Equity Ratio | -2.58 | -5.68 | 3.80 | 0.51 | 2.78 | 2.27 |
Net Debt / EBITDA Ratio | - | 0.15 | -3.16 | -2.76 | -15.88 | -59.27 |
Net Debt / FCF Ratio | - | 0.16 | -2.40 | -1.23 | -37.48 | -22.93 |
Asset Turnover | 0.18 | 0.03 | 0.03 | 0.16 | 0.14 | 0.09 |
Inventory Turnover | 0.71 | 0.75 | 1.76 | 2.45 | 0.99 | 0.14 |
Quick Ratio | 0.41 | 0.80 | 0.52 | 2.05 | 1.05 | 0.97 |
Current Ratio | 1.10 | 1.55 | 1.05 | 2.66 | 1.18 | 3.04 |
Return on Equity (ROE) | -267.63% | -121.47% | -125.00% | 5.06% | -33.24% | -2.12% |
Return on Assets (ROA) | -98.70% | -29.03% | -10.79% | -4.85% | -3.30% | -1.87% |
Return on Invested Capital (ROIC) | - | -62.14% | -22.26% | -10.84% | -7.17% | -3.99% |
Return on Capital Employed (ROCE) | -1806.20% | -638.70% | -26.50% | -14.60% | -6.20% | -3.10% |
Yields
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 5, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Earnings Yield | -7.93% | -5.45% | -29.89% | 1.60% | -10.47% | -0.74% |
FCF Yield | -11.14% | -10.79% | -13.90% | -13.53% | -1.95% | -3.55% |
Buyback Yield / Dilution | 0.00% | 0.00% | 0.34% | -0.34% | -1.12% | -7.89% |
Total Shareholder Return | 0.00% | 0.00% | 0.34% | -0.34% | -1.12% | -7.89% |